Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management. The Company provides Dexcom Seven that can show a new glucose reading every 5 minutes for up to seven days of uninterrupted wear-time to show where glucose levels are, where they have been and where they are going. The system is made up of three technologies: the sensor, transmitter, and receiver. The sensor is a flexible round wire that goes just under the skin to read glucose levels, and attaches to the skin with an adhesive patch. The transmitter snaps into the sensor; it wirelessly sends glucose information to the Receiver every 5 minutes. The receiver displays glucose levels and trends.

Company Growth (employees)
San Diego, US
Size (employees)
1,900 (est)
Dexcom was founded in 1999 and is headquartered in San Diego, US

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr

Dexcom Financials and Metrics

Dexcom Financials

Dexcom's revenue was reported to be $573.3 m in FY, 2016

Revenue (Q3, 2017)

184.6 m

Gross profit (Q3, 2017)

127 m

Gross profit margin (Q3, 2017), %


Net income (Q3, 2017)

(2 m)

EBIT (Q3, 2017)

(500 k)

Market capitalization (13-Dec-2017)

5.1 b

Cash (30-Sep-2017)

402.1 m
Dexcom's current market capitalization is $5.1 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


160 m259.2 m402 m573.3 m

Revenue growth, %


Cost of goods sold

59.9 m82.9 m123.6 m194.9 m

Gross profit

100.1 m176.3 m278.4 m378.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


42.9 m47.1 m58.8 m69 m72.8 m93.2 m105.2 m116.2 m137.3 m148.6 m142.3 m170.6 m184.6 m

Cost of goods sold

15.3 m17.3 m18.9 m21.8 m26.3 m27.2 m30.5 m41.1 m51.8 m47.5 m48.2 m53.1 m57.6 m

Gross profit

27.6 m29.8 m39.9 m47.2 m46.5 m66 m74.7 m75.1 m85.5 m101.1 m94.1 m117.5 m127 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


43.2 m71.8 m86.1 m94.5 m

Accounts Receivable

26.1 m42.4 m74.1 m101.7 m


9 m16 m35.2 m45.4 m

Current Assets

93.1 m145.9 m231.3 m280 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


33.4 m45.7 m49.5 m63.2 m54.2 m67.7 m85.3 m77.9 m87.5 m97.7 m153.5 m395.9 m402.1 m

Accounts Receivable

21.6 m23.8 m28.6 m31.4 m40.2 m45.5 m55.8 m85.9 m101.7 m110.5 m


10 m8.9 m11.6 m14.3 m18.4 m22.4 m30.6 m46.1 m42.9 m44.7 m46.5 m42.8 m43.3 m

Current Assets

81.7 m93.6 m105.5 m123.4 m146.2 m170.4 m203.7 m227.4 m241 m258.6 m330.5 m656.8 m692.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)

Depreciation and Amortization

7 m8.4 m10.8 m15 m

Accounts Receivable

(6.5 m)(16 m)(32 m)(27.2 m)


(1.6 m)(7 m)(19 m)(9.8 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(27.2 m)(12.5 m)(18.5 m)(23.7 m)(12.9 m)(16.6 m)(59.1 m)(19.2 m)(39.4 m)(58.2 m)(41.7 m)(38.8 m)(40.8 m)

Depreciation and Amortization

5.1 m1.9 m3.8 m6 m2.4 m5 m7.7 m3.4 m7.3 m11.4 m3.7 m7.6 m11.9 m

Accounts Receivable

(2 m)2.2 m(2.5 m)(5.3 m)2.2 m(3.1 m)(13.4 m)6.8 m800 k(2.2 m)15.8 m500 k(8.2 m)


(2.5 m)200 k(2.6 m)(5.3 m)(2.4 m)(6.4 m)(14.6 m)(10.9 m)(7.2 m)(8.9 m)(1 m)2.8 m2.2 m
USDY, 2017


97.2 k

Financial Leverage

2.2 x
Show all financial metrics

Dexcom Operating Metrics

FY, 2016

Patents (US)


Patents (foreign)


Patents Pending


Trademarks (US)

Show all operating metrics

Dexcom Market Value History

Dexcom Revenue Breakdown

Dexcom Median Salaries

Source: 23 public H-1B filings from Dexcom

Dexcom's Web-traffic and Trends

Dexcom Online and Social Media Presence

Dexcom News and Updates

POC Blood Glucose Monitoring Devices Market 2017 Global Manufactures : Cercacor, OrSense, Dexcom and Terumo

Market Research Store added a depth and professional market study report on Global POC Blood Glucose Monitoring Devices Market 2017. This report also provides more details about Market Size, Share, Analysis, import/export consumption, supply and demand Figures, cost, price, revenue and gross margins…

Global Diabetes Care Devices Market sales is growing at 5.9% CAGR till 2022

Global diabetic care device market expected to reach USD 26.00 billion by 2021, growing at a CAGR of 5.9% between 2016 and 2021. Posted via Industry Today. Follow us on Twitter @IndustryToday

Dexcom Company Life and Culture

You may also be interested in